Average Co-Inventor Count = 14.64
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Signal Pharmaceuticals, Inc. (19 from 169 patents)
19 patents:
1. 11590139 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
2. 11292796 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
3. 10940152 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
4. 10683298 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
5. 10646493 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
6. 10398700 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
7. 10167290 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
8. 10149849 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
9. 9771371 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
10. 9737541 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
11. 9512124 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
12. 9193692 - Halogen substituted pyrazines as intermediates of mTOR kinase inhibitors
13. 9079900 - Methods of synthesis and purification of heteroaryl compounds
14. 8907087 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
15. 8569494 - Methods of synthesis and purification of heteroaryl compounds